🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic cancer.

“The brilliant light of our household has dimmed his light for us in this life,” his family stated. “After a prolonged and courageous struggle with the disease, we are deeply saddened to declare that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his innovative neo-soul sound and partnerships with high-profile artists.

He launched his first record, “Brown Sugar,” in the mid-nineties to immediate acclaim. The record achieved the fourth spot on Billboard’s Top R&B Albums chart, earned platinum status soon after, and received several award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The record premiered at No. 1 on each of Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The personal depiction showed the artist, notably bare to his waist, singing straight into the lens.

D’Angelo retreated from the spotlight after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a severe vehicle accident that left him in critical condition.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with another No. 1 debut on the soul music rankings and a Grammy for Best R&B Album.

Once more, in his own mysterious way, D’Angelo had limited public outings in the subsequent period.

The musician was scheduled as a top act for the 2025 music event, but his performance was called off, citing an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s health in the weeks before his death, he had reportedly been in the hospital for months and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic cancer, one of the deadliest and hardest to prevent forms of the disease, on a gifted artist whose existence was ended too soon.

“We are saddened that he can only leave dear memories with his family, but we are forever thankful for the legacy of extraordinarily moving music he leaves behind,” his kin said.

Pancreatic Cancer: Deadly and Rarely Preventable

Pancreatic cancer affects the digestive organ, a tiny gland that generates the hormone insulin and is vital in digestion, among additional roles. The position and dimensions of the pancreas in the human system make it more difficult to identify cancer.

Even though this cancer makes up only about 3% of cancer diagnoses each year in the U.S., it is responsible for 7% of cancer deaths.

Almost 70,000 people will be found to have this condition and roughly fifty-two thousand will die of the illness in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have few and ineffective therapies, and a narrow opportunity to make a meaningful impact on the well-being of patients,” said a cancer specialist.

Since pancreatic cancer seldom produces initial signs, it’s often identified only after the condition is advanced. Even when a patient has indicators they are often vague and may be mistaken for a number of everyday ailments.

“As of yet, there is no good way to identify this malignancy in the initial phases, apart from listening to your body and speaking with your physician if there are unfamiliar signs,” explained a health expert.

Common symptoms of this disease encompass:

• abdominal or lower back pain
• reduced body mass
• yellowing of skin and eyes
• reduced hunger
• dark urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• feeling sick

At 51 years old, D’Angelo’s death is an outlier, as pancreatic cancer is most common in individuals in the 65 to 75 range. However, numerous malignancies, such as this type, have become more common among younger adults.

“Pancreatic cancer diagnosed before the age of 50 is deemed rare, yet alarmingly, doctors are noticing a rising count of younger individuals suffering from this disease,” commented a specialist.

Family History Impacts Disease Probability

In the absence of effective screening tools for pancreatic cancer, experts emphasized the importance of knowing your relatives’ health background. Some contributing elements, such as tobacco use and excess weight also have an influence in the onset of pancreatic cancer.

Black individuals have the highest incidence of pancreatic cancer in the United States and are most likely to be found to have inoperable cancer.

“The first step toward reducing one’s chance of this condition is understanding personal risk factors. People should examine their family history, genetic background, and health issues, such as diabetes, long-term pancreas inflammation, or overweight that may increase their susceptibility,” said a medical professional.

Inherited genetic elements are linked to as much as 10% of all pancreatic cancer cases. If a relative in your family has had pancreatic cancer, you may want to think about DNA analysis.

“For individuals with a relative’s background of pancreatic cancer or those carrying high risk DNA changes, checking may involve sophisticated scans such as MRI scans or endoscopic ultrasound (EUS) to detect initial alterations in the organ,” he explained.

For those looking to lower their chance, habit adjustments may make a difference. The best action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreatitis, a risk factor for this malignancy, so limiting or abstaining from alcohol may assist lower your chance.

Managing your weight or shedding pounds may also help reduce your risk. Individuals with obesity are 20% more likely to develop pancreatic cancer. This malignancy also is more frequent in those with diabetes, and weight loss can also lower the chance of type 2 diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are doing better with treatments and newer combination chemotherapy. There are emerging targeted therapies that are already showing results,” remarked a expert.

For numerous people, however, awareness about this uncommon but {dev